CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (unaudited) - USD ($) $ in Millions	Total	Common Stock	Capital in Excess of Par Value	Treasury Stock	Accumulated Other Comprehensive Loss	Retained Earnings
Beginning balance at Dec. 31, 2024	$ 4,372	$ 1	$ 811	$ (1,131)	$ (239)	$ 4,930
Beginning balance (in shares) at Dec. 31, 2024		123,119,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(166)					(166)
Other comprehensive (loss) income	$ 5				5
Common stock repurchase (in shares)	(1,800,000)	(1,766,000)
Common stock repurchase	$ (107)			(107)
Stock-based compensation (in shares)		5,000.000
Stock-based compensation	22		22
CARES Act warrants exercised		810,000
Stock issued under stock plans (in shares)		717,000
Stock issued under stock plans	11		11
Ending balance at Mar. 31, 2025	4,137	$ 1	844	(1,238)	(234)	4,764
Ending balance (in shares) at Mar. 31, 2025		122,885,000
Beginning balance at Dec. 31, 2025	$ 4,118	$ 1	961	(1,701)	(173)	5,030
Beginning balance (in shares) at Dec. 31, 2025	115,530,889	115,531,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	$ (193)					(193)
Other comprehensive (loss) income	$ (3)				(3)
Common stock repurchase (in shares)	(4,700,000)	(4,687,000)
Common stock repurchase	$ (203)			(203)
Stock-based compensation	24		24
Stock issued under stock plans (in shares)		516,000
Stock issued under stock plans	(12)		(12)
Ending balance at Mar. 31, 2026	$ 3,731	$ 1	$ 973	$ (1,904)	$ (176)	$ 4,837
Ending balance (in shares) at Mar. 31, 2026	111,359,830	111,360,000